Camber is offering oxcarbazepine tablets, a generic of Novartis’ Trileptal.
The medication is indicated as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults.
[Read More: Camber debuts generic Epaned]
It is also indicated as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years old and older, and as adjunctive therapy in pediatric patients aged 2 years old and older with partial-onset seizures.
Camber’s oxcarbazepine tablets are available in 150 mg, 300 mg and 600 mg strengths, in 100-count bottles.